Latest news with #LifeMD
Yahoo
5 hours ago
- Health
- Yahoo
Health-E Commerce® expands telehealth offerings with LifeMD™ to provide sleep treatments via FSA Store® and HSA Store®
New collaboration delivers 50% off prescription sleep support for new customers who are struggling with insomnia and sleep disruption DALLAS, June 9, 2025 /PRNewswire/ -- Health-E Commerce, the parent brand of FSA Store and HSA Store, the first and leading online stores dedicated to selling only FSA- and HSA-eligible products and services, announced today that it has expanded its telehealth collaboration with LifeMD™, a leader in virtual care. This latest initiative gives FSA and HSA users affordable, convenient access to FDA-approved prescription sleep treatments at a time when better sleep care is urgently needed. According to the CDC, insufficient sleep is linked to higher risks of obesity, diabetes, heart disease, and depression, which means expanded access to treatment is not just beneficial, it's essential. The arrangement allows new customers who shop at FSA Store or HSA Store to receive 50% off prescription sleep medications from LifeMD, with no in-person appointments required. Following a free virtual consultation, approved patients can have non-addictive, physician-prescribed treatments discreetly delivered to their door, making it easier than ever to address sleep concerns with clinically backed solutions. "The connection between sleep and our overall physical and mental health is undeniable, and poor sleep can even impact our productivity at work and our overall quality of life," said Keri Kaiser, chief revenue officer for Health-E Commerce. "The expansion of our telehealth collaboration with LifeMD gives consumers more options for diagnosing and treating sleep disorders and improving sleep health, while saving money by using tax-free FSA- and HSA-eligible services. We're proud to simplify access to care for millions of Americans and to maximize their healthcare dollars." Many individuals who experience poor sleep rely on over-the-counter remedies that may not be effective for persistent insomnia or sleep disruptions. Fortunately, LifeMD's prescription sleep solutions are designed to address the root causes of poor sleep with medications that target sleep onset, duration, and quality, including Ramelteon, Doxepin, and Trazodone. Eligibility for prescription treatments is determined by a licensed LifeMD physician and backed by LifeMD's 4.9-star patient satisfaction rating. "We're proud to expand our telehealth collaboration with Health-E Commerce to give individuals and families who are enrolled in FSAs and HSAs access to clinical support to improve sleep health and their overall quality of life," said Nicholas Alvarez, co-founder and chief acquisition & growth officer at LifeMD. "Everyone deserves access to quality medical care that is convenient and affordable, and by collaborating with FSA Store and HSA Store, we are able to effectively extend the reach of our services to individuals and families across the country." LifeMD's sleep solutions are now available at and alongside other telehealth services for home sleep apnea testing, CPAP devices and supplies, CPAP alternatives, and more. This launch reinforces Health-E Commerce's mission to make tax-free healthcare dollars work harder for the more than 70 million Americans enrolled in pre-tax health accounts. To learn more or access eligible sleep health services and products, visit or About Health-E CommerceHealth-E Commerce is the parent brand to FSA Store and HSA Store, online stores that serve the 70+ million consumers enrolled in pre-tax health and wellness accounts. The company also created Caring Mill®, a popular private-label line of health products through which a portion of every purchase is donated to the Children's Health Fund. Since 2010, the Health-E Commerce brands have led the direct-to-consumer e-commerce market for exclusively pre-tax health and wellness benefits. Health-E Commerce plays an essential role in expanding eligibility for important new product and telehealth categories within the list of eligible medical expenses. About LifeMDLifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit View original content to download multimedia: SOURCE Health-E Commerce Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Malaysian Reserve
9 hours ago
- Health
- Malaysian Reserve
Health-E Commerce® expands telehealth offerings with LifeMD™ to provide sleep treatments via FSA Store® and HSA Store®
New collaboration delivers 50% off prescription sleep support for new customers who are struggling with insomnia and sleep disruption DALLAS, June 9, 2025 /PRNewswire/ — Health-E Commerce, the parent brand of FSA Store and HSA Store, the first and leading online stores dedicated to selling only FSA- and HSA-eligible products and services, announced today that it has expanded its telehealth collaboration with LifeMD™, a leader in virtual care. This latest initiative gives FSA and HSA users affordable, convenient access to FDA-approved prescription sleep treatments at a time when better sleep care is urgently needed. According to the CDC, insufficient sleep is linked to higher risks of obesity, diabetes, heart disease, and depression, which means expanded access to treatment is not just beneficial, it's essential. The arrangement allows new customers who shop at FSA Store or HSA Store to receive 50% off prescription sleep medications from LifeMD, with no in-person appointments required. Following a free virtual consultation, approved patients can have non-addictive, physician-prescribed treatments discreetly delivered to their door, making it easier than ever to address sleep concerns with clinically backed solutions. 'The connection between sleep and our overall physical and mental health is undeniable, and poor sleep can even impact our productivity at work and our overall quality of life,' said Keri Kaiser, chief revenue officer for Health-E Commerce. 'The expansion of our telehealth collaboration with LifeMD gives consumers more options for diagnosing and treating sleep disorders and improving sleep health, while saving money by using tax-free FSA- and HSA-eligible services. We're proud to simplify access to care for millions of Americans and to maximize their healthcare dollars.' Many individuals who experience poor sleep rely on over-the-counter remedies that may not be effective for persistent insomnia or sleep disruptions. Fortunately, LifeMD's prescription sleep solutions are designed to address the root causes of poor sleep with medications that target sleep onset, duration, and quality, including Ramelteon, Doxepin, and Trazodone. Eligibility for prescription treatments is determined by a licensed LifeMD physician and backed by LifeMD's 4.9-star patient satisfaction rating. 'We're proud to expand our telehealth collaboration with Health-E Commerce to give individuals and families who are enrolled in FSAs and HSAs access to clinical support to improve sleep health and their overall quality of life,' said Nicholas Alvarez, co-founder and chief acquisition & growth officer at LifeMD. 'Everyone deserves access to quality medical care that is convenient and affordable, and by collaborating with FSA Store and HSA Store, we are able to effectively extend the reach of our services to individuals and families across the country.' LifeMD's sleep solutions are now available at and alongside other telehealth services for home sleep apnea testing, CPAP devices and supplies, CPAP alternatives, and more. This launch reinforces Health-E Commerce's mission to make tax-free healthcare dollars work harder for the more than 70 million Americans enrolled in pre-tax health accounts. To learn more or access eligible sleep health services and products, visit or About Health-E CommerceHealth-E Commerce is the parent brand to FSA Store and HSA Store, online stores that serve the 70+ million consumers enrolled in pre-tax health and wellness accounts. The company also created Caring Mill®, a popular private-label line of health products through which a portion of every purchase is donated to the Children's Health Fund. Since 2010, the Health-E Commerce brands have led the direct-to-consumer e-commerce market for exclusively pre-tax health and wellness benefits. Health-E Commerce plays an essential role in expanding eligibility for important new product and telehealth categories within the list of eligible medical expenses. About LifeMDLifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit
Yahoo
9 hours ago
- Health
- Yahoo
Health-E Commerce® expands telehealth offerings with LifeMD™ to provide sleep treatments via FSA Store® and HSA Store®
New collaboration delivers 50% off prescription sleep support for new customers who are struggling with insomnia and sleep disruption DALLAS, June 9, 2025 /PRNewswire/ -- Health-E Commerce, the parent brand of FSA Store and HSA Store, the first and leading online stores dedicated to selling only FSA- and HSA-eligible products and services, announced today that it has expanded its telehealth collaboration with LifeMD™, a leader in virtual care. This latest initiative gives FSA and HSA users affordable, convenient access to FDA-approved prescription sleep treatments at a time when better sleep care is urgently needed. According to the CDC, insufficient sleep is linked to higher risks of obesity, diabetes, heart disease, and depression, which means expanded access to treatment is not just beneficial, it's essential. The arrangement allows new customers who shop at FSA Store or HSA Store to receive 50% off prescription sleep medications from LifeMD, with no in-person appointments required. Following a free virtual consultation, approved patients can have non-addictive, physician-prescribed treatments discreetly delivered to their door, making it easier than ever to address sleep concerns with clinically backed solutions. "The connection between sleep and our overall physical and mental health is undeniable, and poor sleep can even impact our productivity at work and our overall quality of life," said Keri Kaiser, chief revenue officer for Health-E Commerce. "The expansion of our telehealth collaboration with LifeMD gives consumers more options for diagnosing and treating sleep disorders and improving sleep health, while saving money by using tax-free FSA- and HSA-eligible services. We're proud to simplify access to care for millions of Americans and to maximize their healthcare dollars." Many individuals who experience poor sleep rely on over-the-counter remedies that may not be effective for persistent insomnia or sleep disruptions. Fortunately, LifeMD's prescription sleep solutions are designed to address the root causes of poor sleep with medications that target sleep onset, duration, and quality, including Ramelteon, Doxepin, and Trazodone. Eligibility for prescription treatments is determined by a licensed LifeMD physician and backed by LifeMD's 4.9-star patient satisfaction rating. "We're proud to expand our telehealth collaboration with Health-E Commerce to give individuals and families who are enrolled in FSAs and HSAs access to clinical support to improve sleep health and their overall quality of life," said Nicholas Alvarez, co-founder and chief acquisition & growth officer at LifeMD. "Everyone deserves access to quality medical care that is convenient and affordable, and by collaborating with FSA Store and HSA Store, we are able to effectively extend the reach of our services to individuals and families across the country." LifeMD's sleep solutions are now available at and alongside other telehealth services for home sleep apnea testing, CPAP devices and supplies, CPAP alternatives, and more. This launch reinforces Health-E Commerce's mission to make tax-free healthcare dollars work harder for the more than 70 million Americans enrolled in pre-tax health accounts. To learn more or access eligible sleep health services and products, visit or About Health-E CommerceHealth-E Commerce is the parent brand to FSA Store and HSA Store, online stores that serve the 70+ million consumers enrolled in pre-tax health and wellness accounts. The company also created Caring Mill®, a popular private-label line of health products through which a portion of every purchase is donated to the Children's Health Fund. Since 2010, the Health-E Commerce brands have led the direct-to-consumer e-commerce market for exclusively pre-tax health and wellness benefits. Health-E Commerce plays an essential role in expanding eligibility for important new product and telehealth categories within the list of eligible medical expenses. About LifeMDLifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit View original content to download multimedia: SOURCE Health-E Commerce Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Business
- Yahoo
High Insider Ownership Growth Stocks To Watch In May 2025
As the U.S. stock market navigates through a period of slight declines ahead of Nvidia's earnings report, investors are closely watching major indices like the Dow Jones and S&P 500, which have shown resilience despite recent volatility linked to trade policy shifts. In this environment, growth companies with high insider ownership can offer unique insights into potential long-term value, as insiders' stakes often signal confidence in their business models and future prospects amidst fluctuating market conditions. Name Insider Ownership Earnings Growth Atour Lifestyle Holdings (NasdaqGS:ATAT) 22.7% 24% Super Micro Computer (NasdaqGS:SMCI) 25.2% 39.1% Duolingo (NasdaqGS:DUOL) 14.3% 39.9% AST SpaceMobile (NasdaqGS:ASTS) 13.4% 67.1% FTC Solar (NasdaqCM:FTCI) 27.9% 61.8% Credo Technology Group Holding (NasdaqGS:CRDO) 12.1% 65.1% Astera Labs (NasdaqGS:ALAB) 15.2% 44.4% Enovix (NasdaqGS:ENVX) 12.1% 58.4% Upstart Holdings (NasdaqGS:UPST) 12.6% 102.6% BBB Foods (NYSE:TBBB) 16.2% 30.2% Click here to see the full list of 192 stocks from our Fast Growing US Companies With High Insider Ownership screener. Here's a peek at a few of the choices from the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: LifeMD, Inc. is a direct-to-patient telehealth company that facilitates connections between consumers and healthcare professionals for medical care in the United States, with a market cap of $524.01 million. Operations: The company's revenue is derived from its Telehealth segment, which generated $180.05 million, and its Worksimpli segment, which contributed $53.95 million. Insider Ownership: 15.3% LifeMD's growth trajectory is bolstered by its high insider ownership and strategic partnerships, such as the collaboration with Novo Nordisk to offer Wegovy at competitive prices. The company's revenue grew significantly to US$65.7 million in Q1 2025, marking a turnaround from previous losses with a net income of US$1.38 million. Despite volatile share prices and negative equity concerns, LifeMD's expected profitability within three years and innovative telehealth offerings position it well in the expanding weight management market. Unlock comprehensive insights into our analysis of LifeMD stock in this growth report. According our valuation report, there's an indication that LifeMD's share price might be on the cheaper side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Frontier Group Holdings, Inc. operates as a low-fare passenger airline serving leisure travelers in the United States and Latin America, with a market cap of approximately $835.90 million. Operations: The company generates revenue of $3.82 billion from providing air transportation services for passengers. Insider Ownership: 33.5% Frontier Group Holdings' growth potential is highlighted by its forecasted earnings increase of 61.7% annually, outpacing the US market's average. However, recent insider activity shows significant selling over the past three months, raising concerns about confidence in future performance. Despite a volatile share price and a first-quarter net loss of US$43 million, Frontier's revenue is expected to grow at 9.3% per year, slightly above the market average but below high-growth benchmarks. Dive into the specifics of Frontier Group Holdings here with our thorough growth forecast report. Our comprehensive valuation report raises the possibility that Frontier Group Holdings is priced higher than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Tuya Inc. operates in the Internet of Things (IoT) sector, providing related products and services both in China and internationally, with a market cap of approximately $1.45 billion. Operations: The company's revenue is primarily derived from its Internet Software & Services segment, amounting to $311.64 million. Insider Ownership: 29.7% Tuya's recent earnings report highlights its transition to profitability, with a net income of US$11.02 million for Q1 2025, contrasting with a loss the previous year. The company's insider ownership aligns with its strategic initiatives in AIoT and smart energy management, showcased at the 2025 Global Developer Summit. Despite volatile share prices, Tuya's earnings are projected to grow significantly faster than the market average, although revenue growth is expected to be moderate at 15% annually. Get an in-depth perspective on Tuya's performance by reading our analyst estimates report here. Our expertly prepared valuation report Tuya implies its share price may be too high. Access the full spectrum of 192 Fast Growing US Companies With High Insider Ownership by clicking on this link. Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include NasdaqGM:LFMD NasdaqGS:ULCC and NYSE:TUYA. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22-05-2025
- Health
- Yahoo
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes both the medication and access to LifeMD's virtual weight management program. As part of its collaboration with Novo Nordisk announced last month, LifeMD is offering Wegovy® at a discounted price of $199 for eligible patients through its recently completed integration with NovoCare® Pharmacy, with an additional $100 covering LifeMD's clinical care, onboarding, and ongoing support. The collaboration with Novo Nordisk strengthens LifeMD's ability to deliver branded GLP-1 medications through a fully integrated care experience, addressing the needs of the growing number of self-pay patients seeking FDA-approved replacements for compounded therapies. LifeMD's platform provides an end-to-end model—from virtual consultation to prescription fulfillment to ongoing coaching and support—ensuring continuity of care at every stage of the weight loss journey. The $299 bundle is available to eligible patients prescribed Wegovy® on or before June 30, 2025. Beginning with the second month, the program will cost $599 per month, with no long-term commitment required. 'Our collaboration with Novo Nordisk reflects LifeMD's commitment to improving affordability, convenience, and access for patients seeking medically guided weight loss,' said Justin Schreiber, Chairman and CEO of LifeMD. 'This bundled solution provides a seamless, affordable on-ramp to FDA-approved GLP-1 therapy—replacing the fragmented and often inconsistent experience many patients have faced with compounded alternatives. We look forward to expanding this collaboration to reach more patients and drive better outcomes at scale.' 'Novo Nordisk continues to work with LifeMD to expand access to authentic, FDA-approved Wegovy®, a proven therapy for chronic weight management along with a reduced calorie diet and increased physical activity,' said Dave Moore, Executive Vice President, US Operations of Novo Nordisk Inc. 'This collaboration enables patients to begin their treatment journey through a trusted virtual care platform. We look forward to this collaboration and improving access and outcomes for patients nationwide.' LifeMD's weight management program delivers personalized, clinically guided care for patients across the U.S. By leveraging its vertically integrated platform—including a 50-state medical group and national diagnostic lab partnerships—LifeMD offers a seamless experience from consultation through prescription fulfillment and ongoing support. To learn more about LifeMD's $299 introductory bundled offering with Wegovy®, please visit Wegovy® is the first GLP-1 therapy approved in the United States for both chronic weight management and cardiovascular risk reduction in adults with obesity. Through this offering, all doses of Wegovy® are available in an injector pen – by prescription – to eligible LifeMD patients who are uninsured or whose insurance does not cover prescription weight-loss medications. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit Cautionary Note Regarding Forward Looking Statements This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: 'believe,' 'expect,' 'anticipate,' 'project,' 'should,' 'plan,' 'will,' 'may,' 'intend,' 'estimate,' 'predict,' 'continue,' and 'potential,' or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition. Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, 'Risk Factors' identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods. Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation. Investor Contact:Marc Benathen, Chief Financial Officermarc@ Media Contact:Jessica Friedeman, Chief Marketing Officerpress@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
